Targeted Therapy Guided by Circulating Tumor DNA Analysis in Advanced Gastrointestinal Tumors

The GOZILA study, a nationwide, prospective observational circulating tumor (ct)DNA profiling study, previously demonstrated higher clinical trial enrollment rates using liquid biopsy compared with tissue screening. This updated analysis of 4,037 patients further delineated the clinical utility of ctDNA profiling in advanced solid tumor.s